Searched for
SEVELAMER
Aurobindo Pharma arm gets USFDA nod for Sevelamer hydrochloride tabletsAurobindo Pharma Ltd on Wednesday said its wholly-owned subsidiary APL Healthcare has received a final approval from the US health regulato...- Lupin launches generic medication in US marketLupin has launched Sevelamer Hydrochloride tablets (800 mg), used to treat hyperphosphatemia in patients with chronic kidney disease, in th...
- Lupin gains on USFDA nod to market Sevelamer CarbonateAccording to data for September 2021 released by IQVIA MAT September, Sevelamer Carbonate for oral suspension had estimated annual sales of...
- Lupin gets USFDA nod for generic productAs per IQVIA MAT September 2021 data, Sevelamer Carbonate for Oral Suspension had estimated annual sales of USD 51.7 million in the US.
- Lupin gets USFDA nod to market generic Sevelamer Carbonate tabletsThe product is indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease on...
- Glenmark Pharma gets USFDA nod for drug for patients on dialysisThe approved product is a generic version of Genzyme Corporation's Renagel tablets.
- Dr Reddy's launches oral suspension drug in the US marketThe newly launched product is in the strengths of 0.8 g and 2.4 g packets, and is a therapeutic equivalent generic version of Renvela (seve...
- Cipla gets USFDA nod for generic version of Renvela tabletsThe approved product is a generic equivalent to the reference listed drug (RLD), Renvela tablets, 800 mg of Genzyme Corporation, said Cipla.
- Dr Reddy’s Labs climbs after launch of generic Sevelamer carbonate tablets in USShares of the company opened at Rs 2,406 and touched a high and low of Rs 2,415 and Rs 2,355, respectively, in trade so far.
- Sensex adds 266 points, Nifty at 9,870; Nifty PSU Bank lone sectoral loserNifty50 was firm at 9,871, up 82 points or 0.84 per cent around 12:50 pm (IST).
- Top stocks in focus on 3 October 2017Here is a list of top stocks that are likely to be in focus in today's trading session.
- ETMarkets After Hours: Pharma stocks heal market; FMCG reboundsPharma stocks made impressive gains on Wednesday, led by Aurobindo Pharma.
- Aurobindo shares leap with FDA approval for key drugMarkets were anticipating the approval for Sevelamer as it is one of the complex generic drug.
- Aurobindo Pharma gets USFDA nod to market kidney ailment drugAurobindo Pharma has a total of 331 ANDA approvals (294 final nod, including 16 from Aurolife Pharma LLC and 37 tentative approvals) from t...
- Market Now: ITC, HUL among most active stocks in terms of volumeIn the Nifty50 pack, 38 stocks were trading in green, while 13 stocks were in red.
- Market Now: Pharma index top sectoral gainer; Aurobindo, Cipla gainBenchmark indices started the day on a firm note following firm global cues.
- Sensex, Nifty end lower on subdued global cues; RIL gains 2%In the sectoral landscape, BSE Realty index gained the most at 2.16 per cent.
- Aurobindo Pharma gets USFDA nod for oral suspensionSevelamer Carbonate oral suspension is indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialy...
- Hold Cipla Ltd. target Rs 585 : SharekhanHold Cipla Ltd. at a price target of Rs 585. The Cipla management has guided for a double-digit growth in the US and India businesses.
- Don't wait for market bottom, begin stock picking now: 8 top stock ideasAnalysts say the domestic market has turned a fertile ground for stock picking and going for stocks with earnings visibility can prove good...
Load More
